The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Human β-Defensins 2 and 3 Demonstrate Strain-Selective Activity against Oral Microorganisms
Open accessAbstract
Human β-defensins 2 and 3 (HBD-2 and HBD-3) are inducible peptides present at sites of infection in the oral cavity. A few studies have reported broad-spectrum antimicrobial activity for both peptides. However, no comprehensive study has thoroughly investigated their potential against oral pathogens. The purpose of this study was to test the effectiveness of HBD-2 and HBD-3 against a collection of oral organisms ( Actinobacillus actinomycetemcomitans , Fusobacterium nucleatum , Porphyromonas gingivalis , Peptostreptococcus micros , Actinomyces naeslundii , Actinomyces israelii , Streptococcus sanguis , Streptococcus mutans , Candida tropicalis , Candida parapsilosis , Candida krusei , Candida glabrata , and Candida albicans ). Radial diffusion assays were used to test HBD-2 and HBD-3 activities against at least three strains of each species. There was significant variability in MICs, which was strain specific rather than species specific. MICs ranged from 3.9 to >250 μg/ml for HBD-2 and from 1.4 to >250 μg/ml for HBD-3. HBD-3 demonstrated greater antimicrobial activity and was effective against a broader array of organisms. Overall, aerobes were 100% susceptible to HBD-2 and HBD-3, whereas only 21.4 and 50% of the anaerobes were susceptible to HBD-2 and HBD-3, respectively. HBD-2 and HBD-3 also demonstrated strain-specific activity against the Candida species evaluated. Interestingly, an association between HBD-2 and HBD-3 activities was noted. This suggests that the two peptides may have similar mechanisms yet utilize distinct pathways. The lack of activity against specific anaerobic strains and Candida warrants further investigation of the potential resistance mechanisms of these organisms. Finally, the significant variability between strains underlies the importance of testing multiple strains when evaluating activities of antimicrobial peptides.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6
Yang, D., Chertov, O., Bykovskaia, S. N., Chen, Q., Buffo, M. J., Shogan, J., Anderson, M., Schröder, J. M., Wang, J. M., Howard, O. M. Z., et al. (1999) · Science · doi:10.1126/science.286.5439.525 · Cited by 1,809
A peptide antibiotic from human skin
Harder, J., Bartels, J., Christophers, E., & Schröder, J.-M. (1997) · Nature · doi:10.1038/43088 · Cited by 1,363
Isolation and Characterization of Human μ-Defensin-3, a Novel Human Inducible Peptide Antibiotic
Harder, J., Bartels, J., Christophers, E., & Schröder, J.-M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008557200 · Cited by 1,311
Hancock, R. E. (1997) · The Lancet · doi:10.1016/s0140-6736(97)80051-7 · Cited by 1,096
Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis
Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M., & Wilson, J. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81895-4 · Cited by 1,080
Ultrasensitive assays for endogenous antimicrobial polypeptides
Lehrer, R. I., Rosenman, M., Harwig, S. S. S. L., Jackson, R., & Eisenhauer, P. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90021-7 · Cited by 671
Lipid A Acylation and Bacterial Resistance against Vertebrate Antimicrobial Peptides
Guo, L., Lim, K. B., Poduje, C. M., Daniel, M., Gunn, J. S., Hackett, M., & Miller, S. I. (1998) · Cell · doi:10.1016/s0092-8674(00)81750-x · Cited by 649
Production of β-defensins by human airway epithelia
Singh, P. K., Jia, H. P., Wiles, K., Hesselberth, J., Liu, L., Conway, B.-A. D., Greenberg, E. P., Valore, E. V., Welsh, M. J., Ganz, T., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14961 · Cited by 579
Self-citationHuman beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung.
Bals, R., Wang, X., Wu, Z., Freeman, T., Bafna, V, Zasloff, M., & Wilson, J. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2410 · Cited by 577
Widespread expression of beta‐defensin hBD‐1 in human secretory glands and epithelial cells
Zhao, C., Wang, I., & Lehrer, R. I. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)01123-4 · Cited by 561
Discovery of five conserved β-defensin gene clusters using a computational search strategy
Schutte, B. C., Mitros, J. P., Bartlett, J. A., Walters, J. D., Jia, H. P., Welsh, M. J., Casavant, T. L., & McCray, P. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042692699 · Cited by 488
Self-citationSpecific Lipopolysaccharide Found in Cystic Fibrosis Airway Pseudomonas aeruginosa
Ernst, R. K., Yi, E. C., Guo, L., Lim, K. B., Burns, J. L., Hackett, M., & Miller, S. I. (1999) · Science · doi:10.1126/science.286.5444.1561 · Cited by 484
García, J.-R. C., Krause, A., Schulz, S., Rodríguez-Jiménez, F.-J., Klüver, E., Adermann, K., Forssmann, U., Frimpong-Boateng, A., Bals, R., & Forssmann, W.-G. (2001) · The FASEB Journal · doi:10.1096/fj.00-0865fje · Cited by 470
Schröder, J.-M., & Harder, J. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(99)00013-8 · Cited by 453
MECHANISMS OF ADHESION BY ORAL BACTERIA
Whittaker, C. J., Klier, C. M., & Kolenbrander, P. E. (1996) · Annual Review of Microbiology · doi:10.1146/annurev.micro.50.1.513 · Cited by 426
Structure, function, and membrane integration of defensins
White, S. H., Wimley, W. C., & Selsted, M. E. (1995) · Current Opinion in Structural Biology · doi:10.1016/0959-440x(95)80038-7 · Cited by 420
Krisanaprakornkit, S., Kimball, J. R., Weinberg, A., Darveau, R. P., Bainbridge, B. W., & Dale, B. A. (2000) · Infection and Immunity · doi:10.1128/iai.68.5.2907-2915.2000 · Cited by 418
Harder, J., Meyer-Hoffert, U., Teran, L. M., Schwichtenberg, L., Bartels, J., Maune, S., & Schröder, J.-M. (2000) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.22.6.4023 · Cited by 414
García, J.-R., Jaumann, F., Schulz, S., Krause, A., Rodríguez-Jiménez, J., Forssmann, U., Adermann, K., Klüver, E., Vogelmeier, C., Becker, D., et al. (2001) · Cell and Tissue Research · doi:10.1007/s004410100433 · Cited by 410
Cutting Edge: IFN-Inducible ELR− CXC Chemokines Display Defensin-Like Antimicrobial Activity
Cole, A. M., Ganz, T., Liese, A. M., Burdick, M. D., Liu, L., & Strieter, R. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.623 · Cited by 382
Production of β-Defensin Antimicrobial Peptides by the Oral Mucosa and Salivary Glands
Mathews, M., Jia, H. P., Guthmiller, J. M., Losh, G., Graham, S., Johnson, G. K., Tack, B. F., & McCray, P. B. (1999) · Infection and Immunity · doi:10.1128/iai.67.6.2740-2745.1999 · Cited by 374
Self-citationSchibli, D. J., Hunter, H. N., Aseyev, V., Starner, T. D., Wiencek, J. M., McCray, P. B., Tack, B. F., & Vogel, H. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108830200 · Cited by 347
Self-citationThe Structure of Human β-Defensin-2 Shows Evidence of Higher Order Oligomerization
Hoover, D. M., Rajashankar, K. R., Blumenthal, R., Puri, A., Oppenheim, J. J., Chertov, O., & Lubkowski, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006098200 · Cited by 321
Krisanaprakornkit, S., Weinberg, A., Perez, C. N., & Dale, B. A. (1998) · Infection and Immunity · doi:10.1128/.66.9.4222-4228.1998 · Cited by 275
Ganz, T., & Lehrer, R. I. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)00076-f · Cited by 261
Structure and mapping of the human β-defensin HBD-2 gene and its expression at sites of inflammation
Liu, L., Wang, L., Jia, H. P., Zhao, C., Heng, H. H. Q., Schutte, B. C., McCray, P. B., & Ganz, T. (1998) · Gene · doi:10.1016/s0378-1119(98)00480-6 · Cited by 258
Self-citationLocalized antimicrobial peptide expression in human gingiva
Dale, B. A., Kimball, J. R., Krisanaprakornkit, S., Roberts, F., Robinovitch, M., O'Neal, R., Valore, E. V., Ganz, T., Anderson, G. M., & Weinberg, A. (2001) · Journal of Periodontal Research · doi:10.1034/j.1600-0765.2001.360503.x · Cited by 255
Discovery of new human β-defensins using a genomics-based approach
Peng Jia, H., Schutte, B. C., Schudy, A., Linzmeier, R., Guthmiller, J. M., Johnson, G. K., Tack, B. F., Mitros, J. P., Rosenthal, A., Ganz, T., et al. (2001) · Gene · doi:10.1016/s0378-1119(00)00569-2 · Cited by 251
Self-citationMolecular genetics and nomenclature of proteases of Porphyromonas gingivalis
Curtis, M. A., Kuramitsu, H. K., Lantz, M., Macrina, F. L., Nakayama, K., Potempa, J., Reynolds, E. C., & Aduse‐Opoku, J. (1999) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.1999.tb02282.x · Cited by 200
Lysenko, E. S., Gould, J., Bals, R., Wilson, J. M., & Weiser, J. N. (2000) · Infection and Immunity · doi:10.1128/iai.68.3.1664-1671.2000 · Cited by 181
Krisanaprakornkit, S., Kimball, J. R., & Dale, B. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.316 · Cited by 172
Defensin antimicrobial peptides in the oral cavity
Dale, B. A., & Krisanaprakornkit, S. (2001) · Journal of Oral Pathology and Medicine · doi:10.1034/j.1600-0714.2001.300601.x · Cited by 139
Salivary Histatin 5 and Human Neutrophil Defensin 1 Kill Candida albicans via Shared Pathways
Edgerton, M., Koshlukova, S. E., Araujo, M. W. B., Patel, R. C., Dong, J., & Bruenn, J. A. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3310-3316.2000 · Cited by 109
Detection of β-defensins secreted by human oral epithelial cells
Diamond, D. L., Kimball, J. R., Krisanaprakornkit, S., Ganz, T., & Dale, B. A. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(01)00442-2 · Cited by 108
Expression of β‐defensins in gingival health and in periodontal disease
Bissell, J., Joly, S., Johnson, G. K., Organ, C. C., Dawson, D. V., McCray, P. B., & Guthmiller, J. M. (2004) · Journal of Oral Pathology and Medicine · doi:10.1111/j.0904-2512.2004.00143.x · Cited by 102
Self-citationEvidence for a New Type of Outer Membrane Lipid in Oral Spirochete Treponema denticola
Schultz, C. P., Wolf, V., Lange, R., Mertens, E., Wecke, J., Naumann, D., & Zähringer, U. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15661 · Cited by 81
Effect of Ions on Antibacterial Activity of Human Beta Defensin 2
Tomita, T., Hitomi, S., Nagase, T., Matsui, H., Matsuse, T., Kimura, S., & Ouchi, Y. (2000) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2000.tb02559.x · Cited by 81
Starner, T. D., Swords, W. E., Apicella, M. A., & McCray, P. B. (2002) · Infection and Immunity · doi:10.1128/iai.70.9.5287-5289.2002 · Cited by 74
Self-citationSusceptibilities of Oral Bacteria and Yeast to Mammalian Cathelicidins
Guthmiller, J. M., Vargas, K. G., Srikantha, R., Schomberg, L. L., Weistroffer, P. L., McCray, P. B., & Tack, B. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.11.3216-3219.2001 · Cited by 62
Self-citationDeVine, D., Marsh, P. D., Percival, R. S., Rangarajan, M., & Curtis, M. A. (1999) · Microbiology · doi:10.1099/13500872-145-4-965 · Cited by 59
Ganz, T. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.9.f31 · Cited by 42
Treponema denticolaIs Resistant to Human β-Defensins
Brissette, C. A., & Lukehart, S. A. (2002) · Infection and Immunity · doi:10.1128/iai.70.7.3982-3984.2002 · Cited by 42
Cited by
Muteeb, G., Rehman, M. T., Shahwan, M., & Aatif, M. (2023) · Pharmaceuticals · doi:10.3390/ph16111615 · Cited by 1,215
The Roles of Antimicrobial Peptides in Innate Host Defense
Diamond, G., Beckloff, N., Weinberg, A., & Kisich, K. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788682325 · Cited by 642
Oral microbial communities in sickness and in health
Jenkinson, H. F., & Lamont, R. J. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2005.09.006 · Cited by 628
Ageitos, J. M., Sánchez-Pérez, A., Calo-Mata, P., & Villa, T. G. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.09.018 · Cited by 614
A comprehensive summary of LL-37, the factotum human cathelicidin peptide
Vandamme, D., Landuyt, B., Luyten, W., & Schoofs, L. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.11.009 · Cited by 567
Metadata
- Authors
- Joly, S., Maze, C., McCray, P. B., & Guthmiller, J. M.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2004-03
- Volume
- 42
- Issue
- 3
- Pages
- 1024-1029
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- OpenAlex
- W2020137152
- Cited by
- 291
- References
- 42
- FWCI
- 14.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.